|
|
|
|
|
Legal status
Application deemed to be withdrawn
| (51) | INT.CL.: (2006.01) |
A61K 31/427 A61K 31/4353 A61K 31/472 A61K 31/496 A61K 31/513 A61K 31/536 A61K 31/7042 A61K 45/00 A61P 31/00 A61P 43/00 C07D 471/00 |
| (11) | Number of the document | |
| (13) | Kind of document | A |
| (21) | Application number | 2003 003 |
| (22) | Date of filing the application | 2003-01-15 |
| (41) | Date of publication of the application | 2003-11-25 |
| (45) | Date of publication of patent |
| (86) | Number | PCT/US01/22827 |
| Date | 2001-07-20 |
| (87) | Number | WO 02/08226 |
| Date | 2002-01-31 |
| (30) | Number | Date | Country code |
| 60/219,532 | 2000-07-20 | US | |
| 60/284,856 | 2001-04-19 | US |
| (71) |
BRISTOL-MYERS SQUIBB PHARMA COMPANY,
Lawrenceville-Princeton Road, Princeton, New Jersey 08543-4000,
US
|
| (72) |
James D. RODGERS, US
Haisheng WANG, US Mona PATEL, US Argyrios ARVANITIS, US Anthony J. COCUZZA, US |
| (73) |
BRISTOL-MYERS SQUIBB PHARMA COMPANY,
Lawrenceville-Princeton Road, Princeton, New Jersey 08543-4000,
US
|
| (74) |
Rita LAURINAVIČIŪTĖ,
Gedimino pr. 45-6, LT-01109 Vilnius,
LT
|
| (54) | TRICYCLIC 2-PYRIDONE COMPOUNDS USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS |